Chief Scientific Officer, Antabio

I obtained a PhD in Microbiology from the University of Bristol studying the molecular mechanisms of β-lactamase induction and pursued post-doctoral studies within the Antibiotic Research Group, University of Birmingham, on the mechanisms of fluoroquinolone resistance in clinical isolates. In 1996 I joined Glaxo Wellcome integrating anti-tubercular projects from academic collaborators into the internal discovery process. Within GSK, I joined the Molecular Screening department, running a high-throughput screening group and leading several antibacterial and anticancer discovery programs. In 2005 I joined MerLion Pharmaceuticals in Singapore becoming Head of Research, leading the internal research and natural products CRO business, before joining Antabio in late 2012, becoming CSO.

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top